Boris E. Reisberg

453 total citations
11 papers, 318 citations indexed

About

Boris E. Reisberg is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Boris E. Reisberg has authored 11 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in Boris E. Reisberg's work include Antifungal resistance and susceptibility (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Historical Medical Research and Treatments (1 paper). Boris E. Reisberg is often cited by papers focused on Antifungal resistance and susceptibility (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Historical Medical Research and Treatments (1 paper). Boris E. Reisberg collaborates with scholars based in United States. Boris E. Reisberg's co-authors include Donna M. Hacek, Gary A. Noskin, Lance R. Peterson, Marcel E. Conrad, Lewis H. Dennis, Richard Davison, Louis Weinstein, Barry A. Shapiro, Kenneth Kaplan and Laura Mosher and has published in prestigious journals such as Infection and Immunity, Anesthesiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Boris E. Reisberg

11 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boris E. Reisberg United States	9	171	168	69	55	47	11	318
Gary R. Kravitz United States	10	182 1.1×	137 0.8×	83 1.2×	50 0.9×	103 2.2×	14	434
L. O. Gentry United States	9	220 1.3×	239 1.4×	34 0.5×	47 0.9×	27 0.6×	12	415
Ian M. Baird United States	10	166 1.0×	235 1.4×	46 0.7×	53 1.0×	65 1.4×	18	409
W. John Spicer Australia	13	145 0.8×	107 0.6×	37 0.5×	92 1.7×	63 1.3×	34	469
Paolo Carfagna Italy	11	219 1.3×	181 1.1×	45 0.7×	46 0.8×	74 1.6×	24	331
D.H. Forster Germany	9	95 0.6×	109 0.6×	32 0.5×	88 1.6×	36 0.8×	16	412
I. Mohammédi France	11	205 1.2×	99 0.6×	111 1.6×	66 1.2×	57 1.2×	32	372
G J Malanoski United States	6	196 1.1×	152 0.9×	68 1.0×	83 1.5×	128 2.7×	8	389
H. Schuhmacher France	9	124 0.7×	229 1.4×	126 1.8×	65 1.2×	106 2.3×	15	445
Jack Mendelson Canada	6	238 1.4×	118 0.7×	60 0.9×	57 1.0×	136 2.9×	7	372

Countries citing papers authored by Boris E. Reisberg

Since Specialization

Citations

This map shows the geographic impact of Boris E. Reisberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris E. Reisberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris E. Reisberg more than expected).

Fields of papers citing papers by Boris E. Reisberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris E. Reisberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris E. Reisberg. The network helps show where Boris E. Reisberg may publish in the future.

Co-authorship network of co-authors of Boris E. Reisberg

This figure shows the co-authorship network connecting the top 25 collaborators of Boris E. Reisberg. A scholar is included among the top collaborators of Boris E. Reisberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris E. Reisberg. Boris E. Reisberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Hacek, Donna M., et al.. (1999). Medical and Economic Benefit of a Comprehensive Infection Control Program That Includes Routine Determination of Microbial Clonality. American Journal of Clinical Pathology. 111(5). 647–654. 55 indexed citations

2.

Bhattacharya, Mondira, Laura Mosher, Farida Siddiqui, et al.. (1998). Cross-Contamination of Specimens WithMycobacterium tuberculosis:Clinical Significance, Causes, and Prevention. American Journal of Clinical Pathology. 109(3). 324–330. 21 indexed citations

3.

Noskin, Gary A., Jenny Lee, Donna M. Hacek, et al.. (1996). Molecular typing for investigating an outbreak of Candida krusei. Diagnostic Microbiology and Infectious Disease. 26(3-4). 117–123. 15 indexed citations

4.

Venezio, Frank R., et al.. (1985). Mucormycosis After Open Fracture Injury. Southern Medical Journal. 78(12). 1516–1517. 7 indexed citations

5.

Venezio, Frank R., et al.. (1982). Clinical evaluation of moxalactam therapy. Journal of Antimicrobial Chemotherapy. 10(5). 435–443. 6 indexed citations

6.

Reisberg, Boris E.. (1979). Infective endocarditis in the narcotic addict. Progress in Cardiovascular Diseases. 22(3). 193–204. 121 indexed citations

7.

Shapiro, Barry A., et al.. (1975). Serratia Bacteremia from Mean Arterial Pressure Monitors. Anesthesiology. 43(1). 113–114. 27 indexed citations

8.

Reisberg, Boris E.. (1972). Antimicrobial agents and chemotherapy — 1970. Journal of Chronic Diseases. 25(6-7). 417–417. 8 indexed citations

9.

Reisberg, Boris E., et al.. (1971). Cephalexin: Absorption and Excretion as Related to Renal Function and Hemodialysis. Infection and Immunity. 3(4). 540–543. 12 indexed citations

10.

Dennis, Lewis H., et al.. (1969). The Original Haernorrhagic Fever: Yellow Fever. British Journal of Haematology. 17(5). 455–462. 31 indexed citations

11.

Kaplan, Kenneth, Boris E. Reisberg, & Louis Weinstein. (1967). CEPHALORIDINE. The American Journal of the Medical Sciences. 253(6). 667–667. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact